{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:04:08Z","timestamp":1791925448778,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.brachy.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T04:31:48Z","timestamp":1502944308000},"page":"1159-1168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Sophia C.","family":"Kamran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias M.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.07.007_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2015.09.084","article-title":"Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer","volume":"140","author":"Mitra","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2014.08.038","article-title":"Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification","volume":"113","author":"Vargo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.07.007_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brachy.2015.10.010","article-title":"Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience","volume":"15","author":"Perrucci","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.007_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.07.007_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcma.2015.11.005","article-title":"Challenges in the management of recurrent endometrial cancer","volume":"79","author":"Wang","year":"2016","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.brachy.2017.07.007_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jso.24049","article-title":"Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer","volume":"112","author":"Matsuo","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: A review and current management strategies: Part II","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib11","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1525-1438.2008.01198.x","article-title":"Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery","volume":"18","author":"Atahan","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.07.007_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2014.12.036","article-title":"The role of vaginal cuff brachytherapy in endometrial cancer","volume":"136","author":"Harkenrider","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1997.4752","article-title":"Isolated vaginal recurrences in endometrial carcinoma: Treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy","volume":"66","author":"Pai","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: Results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0b013e31829c6757","article-title":"Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites","volume":"33","author":"Moschiano","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.brachy.2017.07.007_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2006.04.037","article-title":"Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer","volume":"66","author":"Viswanathan","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0000000000000376","article-title":"Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: Analysis of outcomes and patterns of recurrence based on pathologic characteristics","volume":"25","author":"Young","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.07.007_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.007_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2013.08.040","article-title":"Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer","volume":"131","author":"Lee","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/IGC.0000000000000615","article-title":"Salvage versus adjuvant radiation treatment for women with early-stage endometrial carcinoma: A matched analysis","volume":"26","author":"Vance","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.07.007_bib24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2012.01.085","article-title":"Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer","volume":"84","author":"Lee","year":"2012","journal-title":"Int\u00a0J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5114\/jcb.2015.54053","article-title":"Brachytherapy for malignancies of the vagina in the 3D era","volume":"7","author":"Glaser","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.007_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2014.06.005","article-title":"Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer","volume":"90","author":"Viswanathan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2015.06.027","article-title":"Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder","volume":"116","author":"Mazeron","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0971-6203.103601","article-title":"Why are we still in the 1950s regarding management of cancer of uterine cervix?","volume":"37","author":"Das","year":"2012","journal-title":"J Med Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib29","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/j.ijrobp.2012.07.1215","article-title":"MRI guided high-dose-rate vaginal interstitial brachytherapy for locally recurrent endometrial cancers","volume":"84","author":"Patil","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/IGC.0b013e3181c4a627","article-title":"Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring","volume":"20","author":"Eskander","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.07.007_bib31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijrobp.2015.03.010","article-title":"Image-based brachytherapy for the treatment of cervical cancer","volume":"92","author":"Harkenrider","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.mri.2012.06.003","article-title":"3-T MR-guided brachytherapy for gynecologic malignancies","volume":"30","author":"Kapur","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.brachy.2017.07.007_bib33","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0","year":"2010"},{"key":"10.1016\/j.brachy.2017.07.007_bib34","series-title":"R: A Language and Environment for Statistical Computing","year":"2016"},{"key":"10.1016\/j.brachy.2017.07.007_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2006.12.021","article-title":"Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours","volume":"68","author":"Viswanathan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.007_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brachy.2011.06.008","article-title":"American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer","volume":"11","author":"Beriwal","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.007_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2015.03.030","article-title":"Rectal bleeding after radiation for endometrial cancer","volume":"115","author":"Mitra","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.007_bib38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2014.06.004","article-title":"Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer","volume":"13","author":"Fokdal","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.007_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brachy.2015.10.001","article-title":"Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity","volume":"15","author":"Amsbaugh","year":"2016","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:11:30Z","timestamp":1761531090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117304075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1538472117304075"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.07.007","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}